ClinConnect ClinConnect Logo
Search / Trial NCT07006662

Anatomical Landmarks for Chest Wall Perforators Used for Partial Breast Reconstruction

Launched by UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST · May 27, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how to better perform partial breast reconstruction for women who have had breast cancer. The study aims to identify specific areas on the chest wall that can help doctors place the reconstruction more effectively. It will take about six months and is currently not recruiting participants.

To be eligible for this study, participants must be women aged 18 and older who are planning to have elective breast surgery and have a body mass index (BMI) of 30 or lower. They should also be willing to give informed consent and follow the study procedures. However, women who are pregnant, have had certain types of previous breast surgeries, or need surgery soon after being screened will not be able to participate. If you join the study, you can expect to contribute to important research that may improve surgical techniques for breast reconstruction in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing elective breast surgery
  • Age ≥ 18 years
  • Female
  • BMI ≤ 30 kg/m2
  • Willing and able to give fully informed consent,
  • Willing and able to comply with the study procedures
  • Exclusion Criteria:
  • Pregnant patients
  • Previous bilateral Breast or axillary surgery
  • Undergoing bilateral oncoplastic procedure or requiring bilateral pre-operative marking
  • Undergoing breast surgery requiring pre-operative marking of some of the landmarks and has had contralateral breast or axillary surgery in the past
  • Surgery planned within 24 hours of screening for eligibility
  • Known history of allergy or contact dermatitis to ultrasound gels

About University Hospitals Of North Midlands Nhs Trust

The University Hospitals of North Midlands NHS Trust is a leading healthcare provider dedicated to delivering high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the Trust plays a vital role in facilitating innovative research initiatives aimed at improving treatment outcomes across various medical disciplines. With a strong commitment to collaboration and ethical practices, the Trust engages in comprehensive clinical trials that contribute to the development of new therapies and enhance clinical knowledge, ultimately benefiting patients and the broader healthcare community.

Locations

Stoke On Trent, , United Kingdom

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported